Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals.

A new delivery formulation (5FU-MS) of 5-fluorouracil (5FU), 5FU incorporated in microspheres composed of poly(glycolide-co-lactide) matrix, has been developed for the treatment of peritoneal carcinomatosis, and is designed to slowly release the incorporated 5FU for 3 weeks. Intraperitoneal 5FU-MS d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagiwara, A., Takahashi, T., Sawai, K., Sakakura, C., Tsujimoto, H., Imanishi, T., Ohgaki, M., Yamazaki, J., Muranishi, S., Yamamoto, A., Fujita, T.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074786/
https://www.ncbi.nlm.nih.gov/pubmed/8912534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074786/
https://www.ncbi.nlm.nih.gov/pubmed/8912534

Ejemplares similares